Akèy › Kansè Metastatik › Kalifòni › Santa Monica
Etid klinik pou Kansè Metastatik nan Santa Monica, CA
19 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Santa Monica (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
- Saint John's Cancer Institute, Santa Monica
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Ap rekriteFaz 1
- ALX Center 11, Santa Monica
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ap rekriteFaz 2/3
- UCLA Health - Santa Monica Cancer Care, Santa Monica
- Cedars-Sinai Medical Center, Beverly Hills · 6 mi lwen
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Kivu Trial Site, Santa Monica
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Ap rekriteFaz 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- UCLA, Santa Monica
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Ap rekriteFaz 1/2
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- ak 1 plis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Sarcoma Oncology Center, Santa Monica
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Ap rekriteFaz 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Ap rekriteFaz 1/2
- UCLA, Santa Monica
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Ap rekriteFaz 2/3
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Ap rekriteFaz 3
- Sarcoma Oncology Research Center, Santa Monica
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Ap rekriteFaz 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Beta-only IL-2 ImmunoTherapY Study
Ap rekriteFaz 1/2
- Providence Saint John's Health Center, Santa Monica
Etid Kansè Metastatik nan lòt vil
- Houston, TX104 etid
- New York City, NY93 etid
- Nashville, TN70 etid
- Boston, MA63 etid
- Los Angeles, CA57 etid
- St. Louis, MO54 etid
- Arlington, VA53 etid
- Philadelphia, PA46 etid
- Chicago, IL45 etid
- San Antonio, TX44 etid
- Washington, DC43 etid
- Dallas, TX42 etid
Lòt etid nan Santa Monica
- Kansè Poumon ki pa ti selil45 etid
- Kansè nan tete28 etid
- Kansè kolorektal23 etid
- Kansè (tout kalite)22 etid
- Kansè poumon15 etid
- Kansè ovè15 etid
- Kansè pwostat15 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak11 etid
- Kansè Endomèt10 etid
- Kansè lestomak9 etid
- Kansè pankreyas9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.